*Staff Member, Department of Pathology, Cleveland Clinic Foundation, Cleveland, OH;
†Assistant Professor, Department of Pathology, Rutgers University, New Jersey Medical School, Newark, NJ;
‡Assistant Professor, Department of Dermatology and Cutaneous Surgery, University of South Florida, Tampa, FL;
§Pathology Resident, Department of Pathology, Medical College of Wisconsin, Milwaukee, WI;
¶Staff Member, Department of Pathology, Sandford Hospital, Bismarck, ND;
‖Staff Member, University of Santo Tomas, Espana, Manila, Philippines;
**Professor, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX; and
††Professor, Departments of Pathology, Medical College of Wisconsin, Milwaukee, WI.
Correspondence: Saul Suster, MD, Professor of Pathology, Medical College of Wisconsin, 9200 W. Wisconsin Avenue, Milwaukee, WI 53226 (e-mail: [email protected]).
V.G. Prieto has disclosed that he was a consultant for Myriad Genetic Laboratories/myPath Melanoma. Lippincott CME Institute has identified and resolved all conflicts of interest concerning this educational activity. All other authors, faculty, and staff in a position to control the content of this CME activity and their spouses/life partners (if any) have disclosed that they have no financial relationships with, or financial interests in, any commercial organizations relevant to this educational activity.
Presented in part at the United States and Canadian Academy of Pathology annual meeting; March 21, 2018; Vancouver, BC, Canada.
Work by S. Ronen, W.-S. Chen, S. K. C. Arudra, and C. Trinidad was performed in the department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
